Calcium folinate pentahydrate
Endometrial Adenocarcinoma
Tarveda TherapeuticsSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Endometrial Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Daniela Matei, MD | Phase 2 | BB |
Capivasertib National Cancer Institute (NCI) | Phase 2 | B |
Olaparib National Cancer Institute (NCI) | Phase 2 | B |
Cediranib National Cancer Institute (NCI) | Phase 2 | B |
Cyclophosphamide Daniela Matei, MD | Phase 2 | B |
View all 22 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →